Aslan Pharmaceuticals Ltd ADR (ASLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASLN | AMGN | GILD | VRTX | BIIB |
| Company | Aslan Pharmaceuticals Ltd ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.5800 | 269.84 | 66.93 | 397.30 | 196.19 |
| High | 0.6121 | 273.14 | 67.57 | 406.34 | 196.77 |
| Low | 0.4300 | 269.84 | 66.74 | 396.00 | 193.23 |
| Last | 0.4550 | 271.91 | 66.95 | 399.92 | 194.11 |
| Change | -0.0570 | +2.98 | +0.19 | +5.64 | -0.27 |
| % Change | -11.13% | +1.11% | +0.28% | +1.43% | -0.14% |
| Volume | 11,382,800 | 2,165,700 | 5,622,300 | 1,393,800 | 1,119,500 |
| 20-Day Average Volume | 813,370 | 2,239,560 | 6,350,505 | 960,430 | 1,143,425 |
| Previous Close | 0.5120 | 268.93 | 66.76 | 394.28 | 194.38 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5486 | 272.35 | 69.61 | 404.73 | 203.84 |
| 20-Day Raw Stochastic | 9.71% | 40.27% | 13.17% | 29.27% | 16.20% |
| 20-Day Relative Strength | 44.06% | 47.06% | 32.36% | 43.46% | 32.22% |
| Weighted Alpha | -91.41 | +10.54 | -20.99 | +15.75 | -38.16 |
| Today's Opinion | 88% Sell | 40% Sell | 100% Sell | 8% Buy | 100% Sell |
| Previous Opinion | 80% Sell | 56% Sell | 100% Sell | 8% Buy | 100% Sell |
| Last Month's Opinion | 24% Sell | 8% Buy | 88% Sell | 40% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.95% since 04/15/24 | +2.41% since 04/15/24 | -1.18% since 04/15/24 | +0.64% since 04/15/24 | -1.37% since 04/15/24 |
| Low | 0.4300 on 04/22/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.6121 on 04/22/24 | 273.14 on 04/22/24 | 67.89 on 04/16/24 | 406.34 on 04/22/24 | 197.73 on 04/16/24 |
| 1-Month | |||||
| %Chg | -30.32% since 03/22/24 | -1.54% since 03/22/24 | -7.80% since 03/22/24 | -3.79% since 03/22/24 | -11.00% since 03/22/24 |
| Low | 0.4300 on 04/22/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.6875 on 03/25/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 218.26 on 03/25/24 |
| 3-Month | |||||
| %Chg | -16.56% since 01/22/24 | -12.33% since 01/22/24 | -14.64% since 01/22/24 | -9.13% since 01/22/24 | -21.82% since 01/22/24 |
| Low | 0.4000 on 02/22/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 2.0900 on 03/12/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 | 251.99 on 01/31/24 |
| 6-Month | |||||
| %Chg | -63.01% since 10/20/23 | -2.47% since 10/20/23 | -13.95% since 10/20/23 | +10.52% since 10/20/23 | -24.60% since 10/20/23 |
| Low | 0.3920 on 12/26/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 2.0900 on 03/12/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,371 | 144,247,584 | 83,121,344 | 101,905,216 | 28,255,270 |
| Shares Outstanding, K | 16,350 | 536,376 | 1,245,077 | 258,459 | 145,361 |
| Annual Sales | 12,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -44,220,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 2,386,300,000 |
| Last Quarter Net Income | -9,710,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 249,700,000 |
| 60-Month Beta | 1.45 | 0.58 | 0.19 | 0.35 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.78 on 04/12/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 04/26/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.09 | 9.85 | 29.28 | 12.93 |